+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

In Vivo CRO Market Research Report by Type (Non-Rodent and Rodent), GLP Type, Indication, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 236 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5666068
UP TO OFF until Mar 31st 2023
The Global In Vivo CRO Market size was estimated at USD 4,089.79 million in 2022, USD 4,466.17 million in 2023, and is projected to grow at a CAGR of 9.68% to reach USD 8,566.51 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global In Vivo CRO Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global In Vivo CRO Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global In Vivo CRO Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global In Vivo CRO Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global In Vivo CRO Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Non-Rodent and Rodent. The Rodent is further studied across Mice and Rats.
  • Based on GLP Type, the market is studied across GLP Toxicology and Non-GLP. The GLP Toxicology is further studied across In House and Outsourcing. The Non-GLP is further studied across In House and Outsourcing.
  • Based on Indication, the market is studied across Autoimmune/inflammation conditions, Blood Cancer, CNS conditions, Diabetes, Obesity, Oncology, Pain management, and Solid Tumor. The Autoimmune/inflammation conditions is further studied across Irritable Bowel Syndrome, Multiple Sclerosis, Osteoarthritis, and Rheumatoid Arthritis. The CNS conditions is further studied across ALS, Epilepsy, Huntington’s Disease, Muscle Regeneration, Parkinson’s Disease, Stroke, and Traumatic Brain Injury. The Pain management is further studied across Acute Pain and Chronic Pain. The Solid Tumor is further studied across Patient-derived Xenograft, Syngeneic Model, and Xenograft.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global In Vivo CRO Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global In Vivo CRO Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global In Vivo CRO Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global In Vivo CRO Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In Vivo CRO Market, including Charles River Laboratories, Crown Bioscience, Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Labcorp Drug Development, Medpace, Inc., MI Bioresearch, Inc., Parexel International Corporation, Pharmacology Discovery Services, PPD Inc., Syneos Health, Syngene International Limited, Taconic Biosciences, Inc., and WuXi AppTec, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global In Vivo CRO Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global In Vivo CRO Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In Vivo CRO Market?
4. What is the competitive strategic window for opportunities in the Global In Vivo CRO Market?
5. What are the technology trends and regulatory frameworks in the Global In Vivo CRO Market?
6. What is the market share of the leading vendors in the Global In Vivo CRO Market?
7. What modes and strategic moves are considered suitable for entering the Global In Vivo CRO Market?
Frequently Asked Questions about the Global In Vivo CRO Market

What is the estimated value of the Global In Vivo CRO Market?

The Global In Vivo CRO Market was estimated to be valued at $4089.79 Million in 2022.

What is the growth rate of the Global In Vivo CRO Market?

The growth rate of the Global In Vivo CRO Market is 9.6%, with an estimated value of $8566.51 Million by 2030.

What is the forecasted size of the Global In Vivo CRO Market?

The Global In Vivo CRO Market is estimated to be worth $8566.51 Million by 2030.

Who are the key companies in the Global In Vivo CRO Market?

Key companies in the Global In Vivo CRO Market include Charles River Laboratories, Crown Bioscience, Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Labcorp Drug Development, Medpace, Inc., MI Bioresearch, Inc. and Pharmacology Discovery Services.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing usage of outsourcing services due to economic benefits
5.1.1.2. Growing investments in the pharmaceutical research by public and private sectors
5.1.1.3. Rising focus on the development of biosimilar medicines and drugs
5.1.2. Restraints
5.1.2.1. High cost associated with the clinical trial processes
5.1.3. Opportunities
5.1.3.1. Globalization of clinical trial processes
5.1.3.2. Competitive landscape in the pharmaceutical sector with patent applications
5.1.4. Challenges
5.1.4.1. Issues related to quality control in In vivo CROs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. In Vivo CRO Market, by Type
6.1. Introduction
6.2. Non-Rodent
6.3. Rodent
6.4.1. Mice
6.4.2. Rats

7. In Vivo CRO Market, by GLP Type
7.1. Introduction
7.2. GLP Toxicology
7.3.1. In House
7.3.2. Outsourcing
7.3. Non-GLP
7.4.1. In House
7.4.2. Outsourcing

8. In Vivo CRO Market, by Indication
8.1. Introduction
8.2. Autoimmune/inflammation conditions
8.3.1. Irritable Bowel Syndrome
8.3.2. Multiple Sclerosis
8.3.3. Osteoarthritis
8.3.4. Rheumatoid Arthritis
8.3. Blood Cancer
8.4. CNS conditions
8.5.1. ALS
8.5.2. Epilepsy
8.5.3. Huntington’s Disease
8.5.4. Muscle Regeneration
8.5.5. Parkinson’s Disease
8.5.6. Stroke
8.5.7. Traumatic Brain Injury
8.5. Diabetes
8.6. Obesity
8.7. Oncology
8.8. Pain management
8.9.1. Acute Pain
8.9.2. Chronic Pain
8.9. Solid Tumor
8.10.1. Patient-derived Xenograft
8.10.2. Syngeneic Model
8.10.3. Xenograft

9. Americas In Vivo CRO Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific In Vivo CRO Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa In Vivo CRO Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Charles River Laboratories
13.2. Crown Bioscience, Inc.
13.3. Eurofins Scientific SE
13.4. Evotec SE
13.5. ICON Plc
13.6. Labcorp Drug Development
13.7. Medpace, Inc.
13.8. MI Bioresearch, Inc.
13.9. Parexel International Corporation
13.10. Pharmacology Discovery Services
13.11. PPD Inc.
13.12. Syneos Health
13.13. Syngene International Limited
13.14. Taconic Biosciences, Inc.
13.15. WuXi AppTec, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL IN VIVO CRO MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL IN VIVO CRO MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL IN VIVO CRO MARKET DYNAMICS
FIGURE 11. GLOBAL IN VIVO CRO MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL IN VIVO CRO MARKET SIZE, BY MICE, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL IN VIVO CRO MARKET SIZE, BY RATS, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2022 VS 2030 (%)
FIGURE 20. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY GLP TYPE, 2030
FIGURE 22. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TOXICOLOGY, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-GLP, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 29. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. GLOBAL IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 31. GLOBAL IN VIVO CRO MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION CONDITIONS, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL IN VIVO CRO MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL IN VIVO CRO MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL IN VIVO CRO MARKET SIZE, BY OSTEOARTHRITIS, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL IN VIVO CRO MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2030 (USD MILLION)
FIGURE 36. GLOBAL IN VIVO CRO MARKET SIZE, BY BLOOD CANCER, 2018-2030 (USD MILLION)
FIGURE 37. GLOBAL IN VIVO CRO MARKET SIZE, BY CNS CONDITIONS, 2018-2030 (USD MILLION)
FIGURE 38. GLOBAL IN VIVO CRO MARKET SIZE, BY ALS, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL IN VIVO CRO MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL IN VIVO CRO MARKET SIZE, BY HUNTINGTON’S DISEASE, 2018-2030 (USD MILLION)
FIGURE 41. GLOBAL IN VIVO CRO MARKET SIZE, BY MUSCLE REGENERATION, 2018-2030 (USD MILLION)
FIGURE 42. GLOBAL IN VIVO CRO MARKET SIZE, BY PARKINSON’S DISEASE, 2018-2030 (USD MILLION)
FIGURE 43. GLOBAL IN VIVO CRO MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
FIGURE 44. GLOBAL IN VIVO CRO MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
FIGURE 45. GLOBAL IN VIVO CRO MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
FIGURE 46. GLOBAL IN VIVO CRO MARKET SIZE, BY OBESITY, 2018-2030 (USD MILLION)
FIGURE 47. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
FIGURE 48. GLOBAL IN VIVO CRO MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
FIGURE 49. GLOBAL IN VIVO CRO MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
FIGURE 50. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
FIGURE 51. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMOR, 2018-2030 (USD MILLION)
FIGURE 52. GLOBAL IN VIVO CRO MARKET SIZE, BY PATIENT-DERIVED XENOGRAFT, 2018-2030 (USD MILLION)
FIGURE 53. GLOBAL IN VIVO CRO MARKET SIZE, BY SYNGENEIC MODEL, 2018-2030 (USD MILLION)
FIGURE 54. GLOBAL IN VIVO CRO MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
FIGURE 55. AMERICAS IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 57. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 58. AMERICAS IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 59. ARGENTINA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. BRAZIL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. CANADA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. MEXICO IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. UNITED STATES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 65. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 66. UNITED STATES IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 67. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 69. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 70. ASIA-PACIFIC IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 71. AUSTRALIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. CHINA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. INDIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. INDONESIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. JAPAN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. MALAYSIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. PHILIPPINES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. SINGAPORE IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. SOUTH KOREA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. TAIWAN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. THAILAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. VIETNAM IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 87. DENMARK IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. EGYPT IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. FINLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. FRANCE IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. GERMANY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. ISRAEL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. ITALY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. NETHERLANDS IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 95. NIGERIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 96. NORWAY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 97. POLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 98. QATAR IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 99. RUSSIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 100. SAUDI ARABIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 101. SOUTH AFRICA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 102. SPAIN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 103. SWEDEN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 104. SWITZERLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 105. TURKEY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 106. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 107. UNITED KINGDOM IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 108. GLOBAL IN VIVO CRO MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 109. GLOBAL IN VIVO CRO MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 110. GLOBAL IN VIVO CRO MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL IN VIVO CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IN VIVO CRO MARKET SIZE, BY MICE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IN VIVO CRO MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IN VIVO CRO MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IN VIVO CRO MARKET SIZE, BY RATS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IN VIVO CRO MARKET SIZE, BY RATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IN VIVO CRO MARKET SIZE, BY RATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IN VIVO CRO MARKET SIZE, BY GLP TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-GLP, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IN VIVO CRO MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IN VIVO CRO MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IN VIVO CRO MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION CONDITIONS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IN VIVO CRO MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IN VIVO CRO MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IN VIVO CRO MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IN VIVO CRO MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IN VIVO CRO MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IN VIVO CRO MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IN VIVO CRO MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IN VIVO CRO MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IN VIVO CRO MARKET SIZE, BY OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IN VIVO CRO MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL IN VIVO CRO MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL IN VIVO CRO MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL IN VIVO CRO MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL IN VIVO CRO MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL IN VIVO CRO MARKET SIZE, BY BLOOD CANCER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL IN VIVO CRO MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL IN VIVO CRO MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL IN VIVO CRO MARKET SIZE, BY CNS CONDITIONS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL IN VIVO CRO MARKET SIZE, BY CNS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL IN VIVO CRO MARKET SIZE, BY CNS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL IN VIVO CRO MARKET SIZE, BY ALS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL IN VIVO CRO MARKET SIZE, BY ALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL IN VIVO CRO MARKET SIZE, BY ALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL IN VIVO CRO MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL IN VIVO CRO MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL IN VIVO CRO MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL IN VIVO CRO MARKET SIZE, BY HUNTINGTON’S DISEASE, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL IN VIVO CRO MARKET SIZE, BY HUNTINGTON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL IN VIVO CRO MARKET SIZE, BY HUNTINGTON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL IN VIVO CRO MARKET SIZE, BY MUSCLE REGENERATION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL IN VIVO CRO MARKET SIZE, BY MUSCLE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL IN VIVO CRO MARKET SIZE, BY MUSCLE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL IN VIVO CRO MARKET SIZE, BY PARKINSON’S DISEASE, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL IN VIVO CRO MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL IN VIVO CRO MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL IN VIVO CRO MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL IN VIVO CRO MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL IN VIVO CRO MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL IN VIVO CRO MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL IN VIVO CRO MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL IN VIVO CRO MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL IN VIVO CRO MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL IN VIVO CRO MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL IN VIVO CRO MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL IN VIVO CRO MARKET SIZE, BY OBESITY, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL IN VIVO CRO MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL IN VIVO CRO MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL IN VIVO CRO MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL IN VIVO CRO MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL IN VIVO CRO MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL IN VIVO CRO MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL IN VIVO CRO MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL IN VIVO CRO MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMOR, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL IN VIVO CRO MARKET SIZE, BY PATIENT-DERIVED XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL IN VIVO CRO MARKET SIZE, BY PATIENT-DERIVED XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL IN VIVO CRO MARKET SIZE, BY PATIENT-DERIVED XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL IN VIVO CRO MARKET SIZE, BY SYNGENEIC MODEL, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL IN VIVO CRO MARKET SIZE, BY SYNGENEIC MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL IN VIVO CRO MARKET SIZE, BY SYNGENEIC MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL IN VIVO CRO MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL IN VIVO CRO MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL IN VIVO CRO MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 125. CANADA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 127. CANADA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. MEXICO IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. CHINA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. CHINA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. CHINA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. INDIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. INDIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. INDIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 153. INDIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. JAPAN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. JAPAN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. JAPAN IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 161. JAPAN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. THAILAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 183. THAILAND IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. THAILAND IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 185. THAILAND IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 198. DENMARK IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. EGYPT IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 200. EGYPT IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. EGYPT IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 202. EGYPT IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 204. FINLAND IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. FINLAND IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 206. FINLAND IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. FRANCE IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. FRANCE IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. ITALY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 220. ITALY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 222. ITALY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. NIGERIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 228. NIGERIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. NORWAY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 232. NORWAY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. NORWAY IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 234. NORWAY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. POLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 236. POLAND IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. POLAND IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 238. POLAND IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. QATAR IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 240. QATAR IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 241. QATAR IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 242. QATAR IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. SPAIN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 256. SPAIN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SPAIN IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. GLOBAL IN VIVO CRO MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 280. GLOBAL IN VIVO CRO MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 281. GLOBAL IN VIVO CRO MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 282. GLOBAL IN VIVO CRO MARKET RANKING, BY KEY PLAYER, 2022
TABLE 283. GLOBAL IN VIVO CRO MARKET SHARE, BY KEY PLAYER, 2022
TABLE 284. GLOBAL IN VIVO CRO MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 285. GLOBAL IN VIVO CRO MARKET MERGER & ACQUISITION
TABLE 286. GLOBAL IN VIVO CRO MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 287. GLOBAL IN VIVO CRO MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 288. GLOBAL IN VIVO CRO MARKET INVESTMENT & FUNDING
TABLE 289. GLOBAL IN VIVO CRO MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 290. GLOBAL IN VIVO CRO MARKET: LICENSE & PRICING

Companies Mentioned

  • Charles River Laboratories
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • ICON Plc
  • Labcorp Drug Development
  • Medpace, Inc.
  • MI Bioresearch, Inc.
  • Parexel International Corporation
  • Pharmacology Discovery Services
  • PPD Inc.
  • Syneos Health
  • Syngene International Limited
  • Taconic Biosciences, Inc.
  • WuXi AppTec, Inc.

Methodology

Loading
LOADING...